![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The cumulative prevalence and incidence of extra-hepatic manifestations in patients with hepatitis C virus infection: real-world evidence from the United States
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Nancy Reau1, Francis Vekeman2, Eric Wu2, Yanjun Bao3, Yuri Sanchez Gonzalez3
1Rush University Medical Center, Chicago, IL; 2Analysis Group, Inc., Boston, MA; 3AbbVie Inc., North Chicago, IL, USA
![0503171](../images/050317/050317-11/0503171.gif)
![0503172](../images/050317/050317-11/0503172.gif)
![0503173](../images/050317/050317-11/0503173.gif)
![0503174](../images/050317/050317-11/0503174.gif)
![0503175](../images/050317/050317-11/0503175.gif)
![0503176](../images/050317/050317-11/0503176.gif)
![0503177](../images/050317/050317-11/0503177.gif)
![0503178](../images/050317/050317-11/0503178.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|